Tıbbi Uygulama Hatasıyla Sonuçlanan Fenilketonüri Vakası

Authors

Hızır Aslıyüksek
Filiz Ekim Çevik
Nihan Hande Akçakaya

Synopsis

Phenylketonuria (PKU) is an autosomal recessive inherited metabolic disorder caused by phenylalanine hydroxylase enzyme deficiency, leading to the accumulation of phenylalanine in the blood and subsequent toxic brain damage. Left untreated, it causes progressive intellectual disability, eczematous rashes, seizures, autistic traits, hyperactivity, and motor function impairments. In Turkey, due to high rates of consanguineous marriages, its prevalence is as high as 1 in every 4,000 births. Diagnosis is established through newborn screening tests using heel-prick blood samples, and the cornerstone of management is a lifelong phenylalanine-restricted diet. In the presented case, a sample was collected on the 10th day after birth and the infant was adopted at 4 months of age; however, because the healthcare staff failed to monitor the positive test result and notify social services or the adoptive family, the diagnosis was delayed. The child exhibited developmental delay and behavioral issues at 21 months of age, and although a definitive diagnosis of PKU was established at 3 years and 4 months of age, permanent sequelae developed due to the delay. This case demonstrates that failure to follow up on mandatory newborn screening tests constitutes a severe medical malpractice issue.

References

https://www.mayoclinic.org/diseases-conditions/phenylketonuria/symptoms-causes/syc-20376302 (Erişim tarihi: 28.04.2021).

Blau N, Van Spronsen FJ. Physician’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Disorders of Phenylalanine and Tetrahydrobiopterin Metabolism. 2014;1:3-21.

Blau N, Van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010;376:1417–27.

Walter JH, White FJ, Hall SK, et al. How practical are recommendations for dietary control in phenylketonuria? Lancet 2002;360:55–57.

Loeber JG. Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis. 2007;30:430–38.

Ozalp I, Coskun T, Tokatli A, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr. 2001;43:97–101.

Zschocke J, Mallory JP, Eiken HG, Nevin NC. Phenylketonuria and the peoples of Northern Ireland. Hum Genet. 1997;100:189–94.

Guldberg P, Henriksen KF, Sipila I, Guttler F, de la Chapelle A. Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland. J Med Genet. 1995;32:976–78

Acosta PB, Matalon KM. Nutrition management of patients with inherited disorders of aromatic amino acid metabolism. In: Acosta PB, editors. Nutrition Management of Patients with Inherited Metabolic Disorders. Boston: Jones and Bartlett Publishers. 2010; 119-74.

Marchant G, Barnes M, Evans JP, LeRoy B and Wolf SM. for the LawSeq Liability Task Force From Genetics to Genomics: Facing the Liability Implications in Clinical Care. The Journal of Law, Medicine & Ethics. 2020; 48: 11-43.

Sage WM. “Medical Liability and Patient Safety,” Health Affairs. 2003 22(4): 26-36.

Ville KD. Medical Malpractice in Twentieth Century United States: The Interaction of Technology, Law and Culture. International Journal of Technology Assessment in Health Care. 1998; 14(2): 197-211.

Greenberg MD. Medical Malpractice and New Devices: Defining an Elusive Standard of Care. Health Matrix. 2009; 19(2): 423-445.

Sokol AJ. and Molzen CJ. The Changing Standard of Care in Medicine: E-Health, Medical Errors, and Technology Add New Obstacles. Journal of Legal Medicine. 2002; 23(4):449-490.

Clayton EW. What Should the Law Say About Disclosure of Genetic Information to Relatives? Health Care Law & Policy. 1998;1(2):373-390.

Suter S. Whose Genes Are These Anyway? Familial Conflict over Access to Genetic Information. Michigan Law Review.1993;91(7):1854-1908.

Offit K. et al., The ‘Duty to Warn’ a Patient’s Family Members about Hereditary Disease Risks. JAMA. 2004; 292(12):1469-1473.

Branum CfR. and Wolf SM. International Policies on Sharing Genomic Research Results with Relatives: Approaches to Balancing Privacy with Access. Journal of Law, Medicine & Ethics. 2015;43(3):576-593.

Brumm, VL, Bilder, D, Waisbren, SE. Psychiatric symptoms and disorders in phenylketonuria. Molec. Genet. Metab. 2010; 99: 59-63.

Published

October 14, 2021

License

License